LEI NIE to Multiple Myeloma
This is a "connection" page, showing publications LEI NIE has written about Multiple Myeloma.
Connection Strength
0.127
-
Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications. Blood Adv. 2018 01 23; 2(2):116-119.
Score: 0.065
-
FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma. Clin Cancer Res. 2017 Nov 15; 23(22):6759-6763.
Score: 0.061